z-logo
open-access-imgOpen Access
Glabridin and Anti-Non-Muscle Myosin IIA Therapy Disrupts Non-Small Cell Lung Carcinoma Motility
Author(s) -
Marie KellyWorden,
Amy Troesch,
Sarah Pruitt,
Ryan G. Rhodes,
Deavin Eviston
Publication year - 2021
Publication title -
advances in lung cancer
Language(s) - English
Resource type - Journals
eISSN - 2169-2718
pISSN - 2169-2726
DOI - 10.4236/alc.2021.102002
Subject(s) - myosin , motility , antibody , wound healing , cell migration , pharmacology , combination therapy , cancer cell , chemistry , medicine , cancer research , cancer , cell , microbiology and biotechnology , biochemistry , immunology , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom